Shopping Cart
- Remove All
- Your shopping cart is currently empty
mTOR inhibitor-18 (Example 106), a mTOR inhibitor, is utilized in research related to various mTOR-associated conditions including cancer, immune disorders, cardiovascular disease, viral infections, inflammation, metabolism/endocrine function disorders, and neurological disorders [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | mTOR inhibitor-18 (Example 106), a mTOR inhibitor, is utilized in research related to various mTOR-associated conditions including cancer, immune disorders, cardiovascular disease, viral infections, inflammation, metabolism/endocrine function disorders, and neurological disorders [1]. |
In vivo | The pharmacokinetics of mTOR inhibitor-18 (Example 106) in rats [1] were evaluated. Dose (mg/kg) C max (μg/mL) AUC 0-t (μg·h/mL) t 1/2 (h) CL (L/h/kg) F%: IV (5 mg/kg): 21.2, 41.455, 1.416, 0.122, PO (10 mg/kg): 9.987, 73.44, 3.258, 0.247, 89. |
Molecular Weight | 431.51 |
Formula | C22H21N7OS |
Cas No. | 2170358-67-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.